Investing

Cathie Wood's ARK Invest Buys Over 800,000 Shares of Signify Health

Thinkstock

One of the ARK exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Friday. This fund bought over 800,000 shares of Signify Health, Inc. (NYSE: SGFY) shares on Friday, as the price of this ETF dropped around 0.5% on Friday. Note that this ETF is still up handily in the last year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 832,666 shares of Signify Health. At Friday’s closing price this would have valued this purchase at $21.9 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 64% in the last year.

Check out all of ARK Invest’s buys for Friday:

Fund Direction Ticker Company Shares
ARKF Buy KSPILI KASPI.KZ JSC 1,867
ARKG Buy SGFY SIGNIFY HEALTH INC 832,666
ARKG Buy RPTX REPARE THERAPEUTICS INC 106,600
ARKG Buy MASS 908 DEVICES INC 14,002
ARKG Buy IOVA IOVANCE BIOTHERAPEUTICS INC 87,910
ARKG Buy CMIIU CM LIFE SCIENCES II INC 1,700
ARKG Buy CDXS CODEXIS INC 44,154
ARKK Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 5,000
ARKK Buy IOVA IOVANCE BIOTHERAPEUTICS INC 123,804
ARKK Buy EXAS EXACT SCIENCES CORP 5,230
ARKK Buy CRSP CRISPR THERAPEUTICS AG 8,000
ARKK Buy COIN COINBASE GLOBAL INC 174,844
ARKQ Buy ACIC ATLAS CREST INVESTMENT CORP 51,420
ARKW Buy COIN COINBASE GLOBAL INC 48,337
ARKX Buy BLDE BLADE AIR MOBILITY INC 91,000

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.